Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
2020-05-07 07:30
Yiling Pharmaceutical Releases Financial Report for Q1 2020, Covid-19 TCM Lianhua Qingwen Research and Achievements Drive Growth
2020-05-06 17:52
Venturis Therapeutics, Inc. Announces its Applications for Four New Patents Related to the Use of Therapeutic Angiogenesis in the Treatment of Illnesses Related to the COVID-19 Virus, as Well as Illnesses Related to Other Viruses
2020-05-06 09:26
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
2020-05-05 20:30
Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets
2020-05-05 20:30
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials
2020-05-05 20:05
Tessa Therapeutics Announces New Executive Leadership
2020-05-05 00:00
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia
2020-05-04 18:30
Yiling Pharmaceutical to Increase Productivity of Lianhua Qingwen
2020-05-04 08:15
Reminder: Deadline To File Claims In The Purdue Pharma L.P. Bankruptcy Is June 30, 2020
2020-05-02 01:19
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic
2020-04-30 20:05
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
2020-04-30 20:00
INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI
2020-04-30 20:00
CPhI & P-MEC China to host 'Virtual Expo Connect' in June
2020-04-30 19:13
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform
2020-04-30 19:00
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
2020-04-29 04:30
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
2020-04-28 20:00
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
2020-04-28 18:57
Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
2020-04-28 08:46
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
2020-04-28 00:00
1
174
175
176
177
178
247